SCHEMBL7982085

SCHEMBL7982085

CNCCc1cccc(N)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 7/20 0.61
MAOA P21397 2/20 0.59
MAOB P27338 2/20 0.59
CHRM2 P08172 1/20 0.58
CHRM1 P11229 1/20 0.58
CHRM3 P20309 1/20 0.58
ATM Q13315 2/20 0.57
CYP19A1 P11511 1/20 0.57
MAPT P10636 2/20 0.48
TP53 P04637 1/20 0.48
CYP1A2 P05177 1/20 0.48
ALOX15 P16050 1/20 0.48
TSHR P16473 1/20 0.48
NFKB1 P19838 1/20 0.48
MAPK1 P28482 1/20 0.48
THPO P40225 1/20 0.48
HIF1A Q16665 1/20 0.48
HSD17B10 Q99714 1/20 0.48
KDM4E B2RXH2 1/20 0.47
GMNN O75496 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15511803 0.89 MEN1 (0.58) TAAR1MAOAMAOBCHRM2CHRM1
SCHEMBL29961813 0.89 MEN1 (0.58) TAAR1MAOAMAOBCHRM2CHRM1
SCHEMBL30394131 0.87 L3MBTL1 (0.61) TAAR1MAOAMAOBCHRM2CHRM1
SCHEMBL15512058 0.87 L3MBTL1 (0.61) TAAR1MAOAMAOBCHRM2CHRM1
SCHEMBL30394446 0.85 SIGMAR1 (0.62) TAAR1MAOAMAOBCHRM2CHRM1
SCHEMBL15511583 0.85 SIGMAR1 (0.62) TAAR1MAOAMAOBCHRM2CHRM1
SCHEMBL8250821 0.81 MAOA (0.55) TAAR1MAOAMAOBCYP19A1PRMT1
SCHEMBL2154372 0.80 MAOB (0.86) MAOAMAOBCYP19A1MAPTALDH1A1
SCHEMBL29436994 0.80 MAOB (0.86) MAOAMAOBCYP19A1MAPTALDH1A1
SCHEMBL14601390 0.80 TAAR1 (0.61) TAAR1CHRM2CHRM1CHRM3ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035513-A1 RESIN COMPOSITION, REINFORCED COMPOSITE MATERIAL, SHAPED PRODUCT, AND METHOD OF RECOVERING REINFORCING FIBER FROM REINFORCED COMPOSITE MATERIAL ASAHI KASEI KABUSHIKI KAISHA (JP) 2026-02-05 US disclosed
EP-4578892-A1 RESIN COMPOSITION, COMPOSITE REINFORCING MATERIAL, MOLDED BODY, AND METHOD FOR RECOVERING REINFORCING FIBERS FROM COMPOSITE REINFORCING MATERIAL Asahi Kasei Kabushiki Kaisha (JP) 2025-07-02 EP disclosed
WO-2025127092-A1 LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2025-06-19 WO disclosed
WO-2024080351-A1 LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2024-04-18 WO disclosed
WO-2024043285-A1 RESIN COMPOSITION, COMPOSITE REINFORCING MATERIAL, MOLDED BODY, AND METHOD FOR RECOVERING REINFORCING FIBERS FROM COMPOSITE REINFORCING MATERIAL 旭化成株式会社 2024-02-29 WO disclosed
WO-2023085390-A1 LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2023-05-19 WO disclosed
WO-2023081230-A1 NOVEL AURISTATIN ANALOGS AND IMMUNOCONJUGATES THEREOF ADCENTRX THERAPEUTICS INC. (US) 2023-05-11 WO disclosed
US-11456184-B2 Substrate processing method and substrate processing system TOKYO ELECTRON LIMITED (JP) 2022-09-27 US disclosed
CN-113316742-A Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal display element, and novel monomer 日产化学株式会社 2021-08-27 CN disclosed
CN-113272729-A Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element 日产化学株式会社 2021-08-17 CN disclosed
CN-104220488-A Novel diamine, polymer, liquid crystal alignment agent, and liquid crystal alignment film, and liquid crystal display element using same NISSAN CHEMICAL IND LTD 2014-12-17 CN disclosed
CN-102171604-B Liquid crystal aligning agent and liquid crystal display element using the same NISSAN CHEMICAL IND LTD 2014-05-14 CN disclosed
CN-103641805-A Diamine, and polyamic acids or polyimides obtained by imidizing polyamic acids NISSAN CHEMICAL IND LTD 2014-03-19 CN disclosed
US-20140066590-A1 POLYIMIDE PRECURSOR MODIFIED WITH DICARBOXYLIC ACID ANHYDRIDE, IMIDIZED POLYIMIDE AND LIQUID CRYSTAL ALIGNING AGENT USING IT NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2014-03-06 US disclosed
CN-103502311-A Polyimide precursor modified with dicarboxylic anhydride, polyimide obtained by imidization, and liquid crystal alignment treatment agent using same NISSAN CHEMICAL IND LTD 2014-01-08 CN disclosed
CN-102947754-A Liquid crystal aligning agent, liquid crystal alignment film using same, and liquid crystal display element NISSAN CHEMICAL IND LTD 2013-02-27 CN disclosed
CN-102754020-A Liquid crystal aligning agent and liquid crystal display element using the same NISSAN CHEMICAL IND LTD 2012-10-24 CN disclosed
WO-2011136371-A1 LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM USING SAME, AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学工業株式会社 (JP) 2011-11-03 WO disclosed
CN-102171604-A Liquid crystal aligning agent and liquid crystal display element using the same NISSAN CHEMICAL IND LTD 2011-08-31 CN disclosed
WO-2010006267-A2 CYCLIC TETRAPEPTIDES UNIVERSITY OF KANSAS (US) 2010-01-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140066590-A1 POLYIMIDE PRECURSOR MODIFIED WITH DICARBOXYLIC ACID ANHYDRIDE, IMIDIZED POLYIMIDE AND LIQUID CRYSTAL ALIGNING AGENT USING IT CCDC22, RCC1, MACF1 TAAR1 3027/4885MAOA 4410/4885MAOB 4432/4885
US-20260035513-A1 RESIN COMPOSITION, REINFORCED COMPOSITE MATERIAL, SHAPED PRODUCT, AND METHOD OF RECOVERING REINFORCING FIBER FROM REINFORCED COMPOSITE MATERIAL TAF1, TAF1L, TAF9 TAAR1 262/4885MAOA 1110/4885MAOB 2358/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.